SCHEMBL22562522

SCHEMBL22562522

N#Cc1c(-n2c3ccc(-c4ccccc4)cc3c3cc(-c4ccccc4)ccc32)cc(-c2cccc(-c3ccccc3)n2)cc1-n1c2ccc(-c3ccccc3)cc2c2cc(-c3ccccc3)ccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
RAB9A P51151 1/20 0.40
ADORA1 P30542 9/20 0.40
ADORA2A P29274 7/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
MAPK1 P28482 1/20 0.38
ALDH1A3 P47895 1/20 0.38
SQOR Q9Y6N5 1/20 0.36
KDM4E B2RXH2 2/20 0.36
HPGD P15428 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
PIM1 P11309 1/20 0.36
PPARG P37231 1/20 0.36
NCOA2 Q15596 1/20 0.36
NCOA1 Q15788 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
KDM5B Q9UGL1 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22562395 0.95 MYC (0.42) MEN1KMT2ARAB9AADORA1ADORA2A
SCHEMBL22562543 0.94 ADORA1 (0.46) MEN1KMT2ARAB9AADORA1ADORA2A
SCHEMBL31273651 0.93 MYC (0.43) MEN1KMT2AADORA1ADORA2AL3MBTL1
SCHEMBL22562397 0.92 MYC (0.40) MEN1KMT2ARAB9AADORA1ADORA2A
SCHEMBL22562530 0.92 ALDH1A3 (0.41) MEN1KMT2ARAB9AADORA1ADORA2A
SCHEMBL22562284 0.92 TGFBR1 (0.38) MEN1KMT2AADORA1ADORA2AL3MBTL1
SCHEMBL22562283 0.92 ADORA1 (0.39) MEN1KMT2ARAB9AADORA1ADORA2A
SCHEMBL19908979 0.91 MYC (0.43) MEN1KMT2AADORA1ADORA2AL3MBTL1
SCHEMBL22562546 0.91 ADORA1 (0.41) MEN1KMT2ARAB9AADORA1ADORA2A
SCHEMBL23296383 0.91 TGFBR1 (0.40) KMT2AADORA1ADORA2AL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-11-20 US disclosed
US-12369492-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2025-07-22 US disclosed
EP-4498784-A2 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux, Inc. (JP) 2025-01-29 EP disclosed
EP-3775100-B1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-01-22 EP disclosed
US-20210135119-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2021-05-06 US disclosed
EP-3418278-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210135119-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 MEN1 3119/4885KMT2A 4132/4885RAB9A 3734/4885
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 MEN1 3119/4885KMT2A 4132/4885RAB9A 3734/4885
US-12369492-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 MEN1 3119/4885KMT2A 4132/4885RAB9A 3734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.